Q1 FY27 snapshot
Announcement Date10-Aug-26
Revenue (Top Line)₹ 1,800 Cr
Net Profit (Bottom Line)₹ 317 Cr
Earnings Per Share (EPS)₹19.21
Expenses₹ 1,311 Cr
Net profit margin (calculated)17.6%
Gland Pharma Ltd. (GLAND) Quarterly Results: Q1 FY27
Quick answer: Gland Pharma Ltd. (NSE: GLAND) reported Q1 FY27 revenue of ₹ 1,800 Cr and net profit of ₹ 317 Cr, with earnings per share (EPS) of ₹19.21, announced on 10-Aug-26.
That works out to a net profit margin of about 17.6% for the quarter.
Note: figures are pulled automatically from company filings and may lag or contain gaps. Verify on NSE or BSE. Not investment advice.
How to read Gland Pharma Ltd.'s Q1 FY27 results
Revenue of ₹ 1,800 Cr is what Gland Pharma Ltd. earned before costs. Net profit of ₹ 317 Cr is what remained for shareholders after expenses, interest and tax. Dividing one by the other gives a net margin of about 17.6%, a quick gauge of how much of each rupee of sales is kept as profit.
New to results? Read our guide on how to read quarterly results, see the full results list or the dividend calendar.
FAQs
Gland Pharma Ltd. results FAQs
What were Gland Pharma Ltd.'s Q1 FY27 results?
Gland Pharma Ltd. (NSE: GLAND) reported Q1 FY27 revenue of ₹ 1,800 Cr and net profit of ₹ 317 Cr, with earnings per share (EPS) of ₹19.21, announced on 10-Aug-26.
What is Gland Pharma Ltd.'s EPS for Q1 FY27?
Gland Pharma Ltd.'s earnings per share for Q1 FY27 was ₹19.21. EPS is net profit divided by the number of outstanding shares.
When did Gland Pharma Ltd. announce its Q1 FY27 results?
Gland Pharma Ltd. announced its Q1 FY27 results on 10-Aug-26.
What is Gland Pharma Ltd.'s net profit margin?
On the reported figures, Gland Pharma Ltd.'s Q1 FY27 net profit margin is about 17.6% (net profit ÷ revenue).